about
CG Oncology Inc is a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients afflicted with bladder cancer. The company's candidate, cretostimogene grenaden...
Read More
53.82
-0.02
(-0.04%)
63,653
XNAS Volume
XNAS 29 Jan, 2026 10:30 AM (EST)
Not Eligible
Expensive Valuation
Technically Bullish
Cg Oncology Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..